ArticleACS nano2025
Modular Virus Capsid Coatings for Biocatalytic DNA Origami Nanoreactors.
Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Confined Catalysis of Enzymes: Enhancement Strategies, Materials, and Biosensor Applications.Journal of functional biomaterials · 2026Review
- DNA-Enzyme Hybrid Nanostructures: Functional Materials to Modulate Enzymatic Activity.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- DNA Nanostructures for siRNA Delivery.Bioconjugate chemistry · 2026Review
- Biological Nanoscaffolds from Hierarchical Construction to Applications.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein cages and custom DNA structures have emerged as self-assembling nanocompartments to sequester enzymes and mimic the compartmentalization of naturally occurring biocatalytic reactions. Protein cages excel in gating the interaction between enzyme and substrate, which can be affected by the physicochemical properties of protein units, whereas the high addressability of DNA origami allows stoichiometric control over the enzyme loading and precise positioning of enzymes. Nevertheless, both approaches would benefit from overcoming the challenges related to controlled enzyme loading and substrate flux, which could be resolved by combining the two nanomaterials. Here, we assemble virus capsid proteins on an enzyme-loaded DNA origami nanoreactor in a modular manner and demonstrate size-selective uptake of substrate molecules depending on the amount and type of capsid protein used for the encapsulation. The capsid cage also protects the biocatalytic unit from degradation, and further functionalization of the reactor surface with an antibody fragment allows targeting for delivery purposes. Thus, our approach provides an attractive platform not only for biomedical applications but also, because of its modularity, for rapid investigation of the physicochemical properties of capsid proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.